Grössmann, N. and Rothschedl, E. and Wolf, S. (2018): Horizon Scanning in Oncology 37th Prioritization – 4th quarter 2018. HSO: 37th Prioritisation.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
For the 37th prioritisation (October 2018), 14 drugs were filtered out of 477 identified and were sent to prioritisation. Of these, 6 drugs were ranked as 'highly relevant' by the expert panel, 7 as 'relevant' and 1 as 'not relevant'. For 'highly relevant' drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.
|Item Type:||DSD: Horizon Scanning in Oncology|
|Subjects:||WB Practice of medicine > WB 300-962 Therapeutics|
QZ Pathology > QZ 200-380 Neoplasms.Cysts
QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
|Series Name:||HSO: 37th Prioritisation|
|Deposited on:||11 Oct 2018 16:16|
|Last Modified:||11 Oct 2018 16:16|
Repository Staff Only: item control page